Everyone is talking about Ozempic. Most of what they’re saying is incomplete.
GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro, Zepbound — are genuinely remarkable drugs. The weight loss is real. The cardiovascular data is striking. For the right person, with the right support, they can be life-changing.
But there’s a story that isn’t getting told. And for women in their 40s who care about long-term health — not just a number on the scale — it matters enormously.
What GLP-1s Actually Are
Originally developed for Type 2 diabetes. They work by slowing gastric emptying, reducing appetite signals in the brain, improving insulin sensitivity, and lowering blood sugar.
Supplement Recommendation
I order everything through The Village Library’s Fullscript dispensary — professional-grade, up to 20% off retail. Same brands used by integrative physicians.
The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in high-risk patients. SURMOUNT-1 showed tirzepatide producing 15-21% body weight reduction over 72 weeks. Not trivial results.
Evidence-based use cases:
- Obesity (BMI ≥ 30) or overweight with comorbidities
- Type 2 diabetes
- High cardiovascular risk
The Story Nobody Is Telling: Muscle Loss
Approximately 25-40% of total weight lost on GLP-1s is lean mass — muscle, bone, and organ tissue — not fat.
This is not a footnote. For women already at risk for sarcopenia and osteoporosis, this is a serious long-term health consideration. Muscle is metabolically active, drives insulin sensitivity, supports bone density, and is harder to rebuild than fat as you age.
The muscle preservation protocol (non-negotiable if you use GLP-1s):
- Resistance training 3x/week minimum, heavy compound movements
- 0.7-1g protein per pound of body weight daily
- Creatine 3-5g/day monohydrate
- HMB 3g/day
Microdosing for Weight Maintenance
One of the more interesting developments: using significantly lower doses — or extending intervals to every 2-4 weeks instead of weekly — to maintain results at dramatically lower cost and with fewer side effects.
A 2025 case series found that patients on extended-interval dosing maintained most of their weight loss. The theory: once habits are established, lower doses may sustain the appetite-regulating effects.
- Cost: Standard weekly dosing: $1,000+/month. Microdosing: potentially $100-200/month
- Side effects: Dose-dependent — lower doses typically mean less nausea and GI distress
- Important: Not an FDA-approved protocol. Primarily done with compounded versions. Requires a knowledgeable physician.
Microdosing Beyond Weight Loss
The most fascinating emerging research on GLP-1 microdosing isn’t about weight at all.
Perimenopause and metabolic health:
Perimenopause brings significant insulin resistance independent of weight. GLP-1s improve insulin sensitivity directly. Low-dose GLP-1s are being explored for perimenopausal women dealing with metabolic shifts that don’t respond to lifestyle changes alone.
PCOS:
Already well-studied. GLP-1s address the insulin resistance that drives PCOS symptoms — irregular cycles, androgen excess, weight gain. Low-dose protocols showing significant benefit.
Brain health and neuroprotection:
GLP-1 receptors exist throughout the brain. Early research suggests GLP-1 agonists may reduce neuroinflammation and amyloid accumulation — hallmarks of Alzheimer’s disease. Clinical trials are underway. For women with APOE4 or family history of dementia, this research is worth watching closely.
The “food noise” phenomenon:
Many patients report that constant mental chatter about food — cravings, obsessive thinking — simply quiets. Emerging research suggests GLP-1s may modulate reward pathways beyond appetite. Early data on alcohol reduction is also appearing.
The reframe: GLP-1s may ultimately be understood less as “weight loss drugs” and more as metabolic and neuroprotective agents — with weight loss as one of several beneficial effects.
The Rebound Problem
When you stop — and cost causes most people to eventually stop — appetite and weight return, often rapidly. People who maintain results long-term are the ones who built habits while on the medication.
Access and Cost
- Branded: $800-$1,400/month without insurance
- Compounded versions: significantly cheaper, but quality control risks apply
- Telehealth platforms: Ro and Hers offer online consultations with licensed prescribers at lower cost than traditional medical visits
The Supplement Stack
For professional-grade supplements at practitioner pricing — creatine, HMB, protein — Fullscript offers the same brands used by integrative physicians at a discount.
Amazon: Creatine Monohydrate →
Amazon: HMB Supplement →
Amazon: Protein Powder →
Noel’s Take
GLP-1s are a tool — a genuinely powerful one for the right person. They are not a shortcut. The drug handles appetite. You still have to handle everything else.
The emerging non-weight applications are the most exciting development in this space. If you’re navigating perimenopause, have family history of Alzheimer’s, or are dealing with metabolic shifts that aren’t responding to lifestyle changes — this is a conversation worth having with a physician who stays current with the research.
Book a Consultation — $500 →
Related reading:
- The Bone Density Crisis Nobody Talks About Until It’s Too Late
- The GLP-1 Muscle Preservation Stack
- Perimenopause: What Nobody Tells You Until You’re Already In It
You Might Also Like
The information in this post is for educational purposes only and does not constitute medical advice. Please consult a qualified physician for guidance specific to your situation. Some links are affiliate links — see our full Affiliate Disclosure.